1. Malaysia Stocks

  2. •

    Process industries

  3. •

    Chemicals: agricultural
All Cosmos Bio-Tech Holding Corp.

All Cosmos Bio-Tech Holding Corp.

TTWSE:4148
30.35
TWD
-0.45
(-1.46%)
3.67EPS
10.92P/E
2.04BMarket Cap
Nov 18Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
35.72
41.06
38.38
34.82
35.46
39.97
26.29
24.43
32.68
55.06
42.04
36.57
43.86
47.42
Basic EPS, GAAP
3.02
3.6
3.35
4.1
5.06
4.54
0.53
1.22
2.95
5.48
2.07
1.91
2.28
2.78
Free Cash Flow per Basic Share
-1.86
0.05
1.44
8.35
2.29
-4.13
12.56
-2.41
-2.55
-0.25
11.84
-1.31
3.11
2.84
Dividend per Share
0.37
2.3
1.44
0.95
1.9
2.52
2.29
0.95
0.95
1.43
2.38
0.95
0.48
- -
Book Value per Share
17.54
21.68
20.81
22.47
30.33
32.31
30.43
29.55
29.6
35.2
33.53
37.41
40.8
41.21
Tangible Book Value per Share
17.52
21.63
20.78
22.42
30.29
32.18
30.39
29.52
29.58
35.19
33.38
37.24
40.63
41.06
Basic Weighted Avg Shares
52
54
59
59
64
67
67
67
67
67
67
67
67
67
Sales/Revenue/Turnover
1,875
2,231
2,257
2,066
2,264
2,688
1,768
1,643
2,197
3,702
2,827
2,459
2,949
3,174
Operating Margin (%)
7.45
7.92
12.58
15.71
17.97
14.24
6.81
5.79
9.68
17.82
6.65
6.66
10.3
10.66
Depreciation Expense
43
50
48
54
41
46
53
50
49
49
49
54
66
67
Net Income, GAAP
158
196
197
243
323
305
36
82
198
368
139
129
153
186
Effective Tax Rate (%)
1.99
3.94
3.17
11.58
2.58
12.61
62.74
34.41
26.41
28.07
26.52
30.97
30.65
29.27
Profit Margin (%)
8.45
8.77
8.73
11.77
14.26
11.35
2.02
5
9.02
9.95
4.93
5.23
5.19
5.85
Working Capital
450
644
711
912
1,680
1,743
1,613
1,606
1,740
2,685
2,028
2,182
2,449
2,517
LT Debt
155
150
103
68
46
22
5
1
1
536
30
18
127
119
Total Equity
1,158
1,405
1,426
1,558
2,345
2,536
2,426
2,363
2,379
2,863
2,814
3,130
3,445
3,503
Return on Invested Capital (%)
9.78
10.84
11.57
13.97
17.89
11.95
1.05
2.76
7.8
14.58
3.86
3.17
5.66
6.06
Return on Capital (%)
12.81
13.09
9.74
10.54
11.9
10.67
1.4
2.85
6.38
9.05
2.58
2.57
3.04
3.65
Return on Common Equity (%)
15.2
16.81
15.63
18.95
19.15
14.49
1.69
4.08
9.96
16.9
6.03
5.39
5.82
7.2

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
254
160
494
LT Borrowings
125
122
116
LT Finance Leases
2
4
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
67
67
67
Market Capitalization
2,575
2,925
2,037

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,063
3,085
3,397
Cash, Cash Equivalents & STI
1,444
1,540
1,419
Accounts Receivable, Net
858
561
852
Inventories
676
860
1,018
Total Current Liabilities
614
652
880
Payables & Accruals
- -
- -
- -
ST Debt
254
160
494
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
10.16%
8.12%
10.05%
Free Cash Flow
-570.88%
-1,061.94%
-337.49%
Net Income, GAAP
26.86%
35.19%
18.98%
Sales/Revenue/Turnover
6.4%
17.11%
19.95%
Total Cash Common Dividend
- -
- -
-50%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
524
478
746
710
2,459
2025
548
740
830
832
2,949
2026
528
985
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.42
0.11
1.07
0.3
1.91
2025
0.2
0.54
1.02
0.52
2.28
2026
0.08
1.14
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.95
2025
- -
- -
- -
- -
0.48
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Shih Hao Peng
Full Time Employees
368
Sector
Process industries
Industry
Chemicals: agricultural
Address
PLO 650, Jalan Keluli 7 Pasir Gudang HO Malaysia 81700
IPO Date
Jun 8, 2017
Website
allcosmos.com
Similar Companies
UPL Limited (NSE:UPL)
Mosaic Company (The) (NYSE:MOS)
CF Industries Holdings, Inc. (NYSE:CF)
PhosAgro (MOEX:PHOR)
Abou Kir Fertilizers & Chemical Industries Co. (EGX:ABUK)
Misr Fertilizers Production Company MOPCO (EGX:MFPC)
Business
All Cosmos Bio-Tech Holding Corporation engages primarily in the research, development, manufacturing, and sale of pharmaceutical, cosmetic, and health food products. The company’s core offerings include proprietary bio-technology derived active ingredients, skin care solutions, nutraceuticals, and functional food products marketed under various brands. It caters to markets in Taiwan, China, and other Asian regions, focusing on innovation-driven products derived from advanced bio-technology and natural resources. Founded in 1991, the company is headquartered in Taipei, Taiwan. Recently, All Cosmos Bio-Tech Holding Corporation has made significant strides in expanding its product portfolio and market reach. In the last 1-2 years, the company launched new innovative skin care lines that integrate advanced bioactive compounds, forming strategic partnerships to enhance research capabilities and distribution networks. It has also pursued collaborations for technology development with regional biotech firms, reflecting a strategic emphasis on expanding its health and beauty segment. Operational enhancements include modernization of manufacturing facilities aimed at increasing capacity and product quality. The company operates through multiple subsidiaries focused on distinct business segments such as cosmetics, pharmaceuticals, and health supplements. Target customers range from individual consumers seeking premium personal care products to institutional clients in the healthcare and wellness sectors. All Cosmos Bio-Tech Holding Corporation’s positioning leverages its strong R&D foundation and biotechnological expertise to compete in the fast-growing Asian health and beauty industry. In summary, All Cosmos Bio-Tech Holding Corporation is a Taiwanese biotechnology and healthcare company specializing in bioactive ingredient development, skin care, nutraceuticals, and health food products. It has recently bolstered its innovation pipeline and operational capabilities through new product launches and strategic partnerships, serving markets primarily in Taiwan and greater Asia since its establishment in 1991. The company’s headquarters remain in Taipei with ongoing expansions in product and technological dimensions to sustain growth and market presence.